{"id":"W4328130008","doi":"10.1002/jvc2.126","title":"Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q)","year":2023,"lang":"en","type":"article","venue":"JEADV Clinical Practice","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"Eli Lilly and Company; American Academy of Dermatology","keywords":"Ixekizumab; Psoriasis; Medicine; Placebo; Randomized controlled trial; Sex organ; Quality of life (healthcare); Internal medicine; Physical therapy; Dermatology; Secukinumab; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003358131,0.0005946853,0.001949474,0.0003661089,0.0002153599,0.00006994593,0.0003735373,0.0007363422,0.0001213986],"category_scores_gemma":[0.005224774,0.0004286141,0.0003826552,0.001011789,0.0002844401,0.0006073305,0.0001854764,0.001186616,0.0006770635],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001820549,"about_ca_system_score_gemma":0.0002592466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003967134,"about_ca_topic_score_gemma":0.0003197689,"domain_scores_codex":[0.9915978,0.003299747,0.002530542,0.001357837,0.0002575175,0.0009565974],"domain_scores_gemma":[0.9920995,0.005898019,0.0008178216,0.000732004,0.0002794428,0.0001731608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9240441,0.00908234,0.02485369,0.00001870301,0.001180931,0.0003172036,0.0002613367,0.0001288022,0.0000994203,0.00002127251,0.0003041909,0.03968799],"study_design_scores_gemma":[0.9395476,0.01138559,0.04551656,0.0000980045,0.0007632874,0.00001742975,0.0002290027,0.00009745017,0.00046016,0.00002501735,0.00118848,0.000671397],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933841,0.0001233168,0.00004345141,0.0005643842,0.001282882,0.003919782,0.0001147015,0.0001610516,0.0004063897],"genre_scores_gemma":[0.9946037,0.0002403127,0.0009883457,0.0004207632,0.0003397966,0.0008274175,0.0004318252,0.00007817923,0.002069649],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0390166,"threshold_uncertainty_score":0.9998165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04441120760223758,"score_gpt":0.354716591823644,"score_spread":0.3103053842214064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}